• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker hits a new lifetime high in shares | Medtech Wall Street news for the week of Apr. 7, 2014

Stryker hits a new lifetime high in shares | Medtech Wall Street news for the week of Apr. 7, 2014

April 10, 2014 By MassDevice Contributors Network

Stryker shares hit new lifetime high | MassDevice.com On Call

April 7, 2014 by Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — Medtech titan Stryker hit a new lifetime high on Friday with shares rising to $84.85 apiece.

The share spiked after a gradual incline over the course of Thursday, April 3, peaking in the late morning on Friday before settling down to close at $82.60, a 1.8% drop on the day. Read more

TriVascular Technologies sets price range for $98M IPO

April 4, 2014 by Brad Perriello

TriVascular Technologies sets price range for $98M IPO

TriVascular Technologies said it could raise as much as $98 million from its planned initial public offering after setting the per-share price range at $13-$15.

That would set the top end of the 6.5-million-share offering at $97.5 million, or $84.5 million at the low end. Read more

Deerfield raises $1.6B healthcare fund

April 8, 2014 by Brad Perriello

Deerfield raises $1.6B healthcare fund

Deerfield Management Co. said it raised a fund aimed at healthcare investments that’s worth $1.6 billion.

Deerfield Private Design Fund III is "designed to provide flexible private financing to healthcare companies," according to a press release. Read more

Vital Therapies lowers the bar with 2nd IPO try

April 7, 2014 by Brad Perriello

Vital Therapies lowers the bar with 2nd IPO try

Bio-artificial liver maker Vital Therapies set the range for its initial public offering at $13 to $15 per share, below the $16 to $18 range it set last year before scuttling its 1st try at a U.S. IPO.

In March Vital Therapies filed updated registration statements signaling its intent to launch the IPO, wiping clean the pricing set in November 2013. Another filing today set the new price range for the 4.5-million-share offering at $58.5 million to $67.5 million. Read more

Delcath Systems tanks following reverse stock split

April 9, 2014 by Arezu Sarvestani

Delcath Systems tanks following news of reverse stock split

Shares of Delcath dropped more than 18% by the early afternoon today after the company proceeded with a 1-to-16 reverse stock split.

The slide unraveled the stock’s gradual rise over the course of 2014, leaving shares down nearly 6% for the year. Shares had briefly traded as high as $6.72 apiece in March. Read more

Filed Under: News Well, Wall Street Beat Tagged With: Cytomedix Inc., Deerfield Management, Delcath Systems Inc., NASDAQ, Stryker, TriVascular, Vital Therapies

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy